Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CalciMedica, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Diagnosis of acute pancreatitis established by the presence of abdominal pain consistent with acute pancreatitis, and 1 of the following 2 criteria:
1. Serum lipase and/or serum amylase \> 3 times the upper limit of normal (ULN);
2. Characteristic findings of acute pancreatitis on abdominal imaging;
2. Adults ≥ 18 years of age;
3. A female patient of child-bearing potential who is sexually active with a male partner must be willing to practice acceptable methods of birth control for 365 days after the last dose of CM4620-IE;
4. A male patient who is sexually active with a female partner of childbearing potential must be willing to practice acceptable methods of birth control for 365 days after the last dose of CM4620-IE and must not donate sperm for 365 days;
5. Willing and able to, or have a legal authorized representative (LAR) who is willing and able to, provide informed consent to participate, and cooperate with all aspects of the protocol.
You may not be if
1. Any concurrent clinical condition that a study physician believes could potentially pose an unacceptable health risk to the patient while involved in the study or may limit expected survival to \< 6 months;
2. Suspected presence of cholangitis in the judgment of the treating investigator;
3. Any malignancy being treated with chemotherapy or immunotherapy;
4. Any autoimmune disease being treated with immunosuppressive medication or immunotherapy (Section 5.3 for list of prohibited medications);
5. History of:
1. Chronic pancreatitis, pancreatic necrosectomy, or pancreatic enzyme replacement therapy;
